{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:04Z","timestamp":1791920044910,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1124\/jpet.108.149872","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T02:50:02Z","timestamp":1236221402000},"page":"967-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pentamidine Movement across the Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers: Effect of Trypanosome Infection, Combination Therapy, P-Glycoprotein, and Multidrug Resistance-Associated Protein"],"prefix":"10.1016","volume":"329","author":[{"given":"Lisa","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Dogruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry Pieter","family":"De Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Ann","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.149872_bib1","doi-asserted-by":"crossref","unstructured":"Balasegaram M, Harris S, Checchi F, Hamel C, and Karunakara U (2006) Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ 84: 777-782.","DOI":"10.2471\/BLT.05.028399"},{"key":"10.1124\/jpet.108.149872_bib2","doi-asserted-by":"crossref","unstructured":"Basselin M, Denise H, Coombs GH, and Barrett MP (2002) Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob Agents Chemother 46: 3731-3738.","DOI":"10.1128\/AAC.46.12.3731-3738.2002"},{"key":"10.1124\/jpet.108.149872_bib3","doi-asserted-by":"crossref","unstructured":"Berger BJ, Reddy VV, Le ST, Lombardy RJ, Hall JE, and Tidwell RR (1991) Hydroxylation of pentamidine by rat liver microsomes. J Pharmacol Exp Ther 256: 883-889.","DOI":"10.1016\/S0022-3565(25)23190-1"},{"key":"10.1124\/jpet.108.149872_bib4","doi-asserted-by":"crossref","unstructured":"Borst P and Schinkel AH (1997) Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet 13: 217-222.","DOI":"10.1016\/S0168-9525(97)01112-8"},{"key":"10.1124\/jpet.108.149872_bib5","doi-asserted-by":"crossref","unstructured":"Bridges DJ, Gould MK, Nerima B, M\u00e4ser P, Burchmore RJ, and de Koning HP (2007) Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes. Mol Pharmacol 71: 1098-1108.","DOI":"10.1124\/mol.106.031351"},{"key":"10.1124\/jpet.108.149872_bib6","doi-asserted-by":"crossref","unstructured":"Bronner U, Doua F, Ericsson O, Gustafsson LL, Mi\u00e9zan TW, Rais M, and Rombo L (1991) Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Cote d\u2019Ivoire. Trans R Soc Trop Med Hyg 85: 608-611.","DOI":"10.1016\/0035-9203(91)90364-5"},{"key":"10.1124\/jpet.108.149872_bib7","doi-asserted-by":"crossref","unstructured":"Burri C and Brun R (2003) Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res 90 (Suppl 1): S49-S52.","DOI":"10.1007\/s00436-002-0766-5"},{"key":"10.1124\/jpet.108.149872_bib8","doi-asserted-by":"crossref","unstructured":"Carter NS and Fairlamb AH (1993) Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 361: 173-176.","DOI":"10.1038\/361173a0"},{"key":"10.1124\/jpet.108.149872_bib9","doi-asserted-by":"crossref","unstructured":"Coelho AC, Beverley SM, and Cotrim PC (2003) Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol Biochem Parasitol 130: 83-90.","DOI":"10.1016\/S0166-6851(03)00162-2"},{"key":"10.1124\/jpet.108.149872_bib10","doi-asserted-by":"crossref","unstructured":"Cordon-Cardo C, O\u2019Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, and Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 86: 695-698.","DOI":"10.1073\/pnas.86.2.695"},{"key":"10.1124\/jpet.108.149872_bib11","doi-asserted-by":"crossref","unstructured":"de Koning HP (2001) Transporters in African trypanosomes: role in drug action and resistance. Int J Parasitol 31: 512-522.","DOI":"10.1016\/S0020-7519(01)00167-9"},{"key":"10.1124\/jpet.108.149872_bib12","doi-asserted-by":"crossref","unstructured":"Donnelly H, Bernard EM, Rothkotter H, Gold JW, and Armstrong D (1988) Distribution of pentamidine in patients with AIDS. J Infect Dis 157: 985-989.","DOI":"10.1093\/infdis\/157.5.985"},{"key":"10.1124\/jpet.108.149872_bib13","doi-asserted-by":"crossref","unstructured":"Doua F, Miezan TW, Sanon Singaro JR, Boa Yapo F, and Baltz T (1996) The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg 55: 586-588.","DOI":"10.4269\/ajtmh.1996.55.586"},{"key":"10.1124\/jpet.108.149872_bib14","doi-asserted-by":"crossref","unstructured":"Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow JD, Tiribelli C, and Ghersi-Egea JF (2008) Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol 510: 497-507.","DOI":"10.1002\/cne.21808"},{"key":"10.1124\/jpet.108.149872_bib15","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Martin G, Thambo S, Paulos C, V\u00e1squez I, and Paredes J (1992) The pharmacokinetics of nifurtimox in chronic renal failure. Eur J Clin Pharmacol 42: 671-673.","DOI":"10.1007\/BF00265935"},{"key":"10.1124\/jpet.108.149872_bib16","doi-asserted-by":"crossref","unstructured":"Huai-Yun H, Secrest DT, Mark KS, Carney D, Brandquist C, Elmquist WF, and Miller DW (1998) Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun 243: 816-820.","DOI":"10.1006\/bbrc.1997.8132"},{"key":"10.1124\/jpet.108.149872_bib17","doi-asserted-by":"crossref","unstructured":"Kennedy PG (2006) Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol 36: 505-512.","DOI":"10.1016\/j.ijpara.2006.01.012"},{"key":"10.1124\/jpet.108.149872_bib18","doi-asserted-by":"crossref","unstructured":"Lejon V, Legros D, Savignoni A, Etchegorry MG, Mbulamberi D, and B\u00fcscher P (2003) Neuro-inflammatory risk factors for treatment failure in \u201cearly second stage\u201d sleeping sickness patients treated with pentamidine. J Neuroimmunol 144: 132-138.","DOI":"10.1016\/j.jneuroim.2003.08.033"},{"key":"10.1124\/jpet.108.149872_bib19","doi-asserted-by":"crossref","unstructured":"Leprohon P, L\u00e9gar\u00e9 D, Girard I, Papadopoulou B, and Ouellette M (2006) Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryot Cell 5: 1713-1725.","DOI":"10.1128\/EC.00152-06"},{"key":"10.1124\/jpet.108.149872_bib20","doi-asserted-by":"crossref","unstructured":"Likeufack AC, Brun R, Fomena A, and Truc P (2006) Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960\u20131995 and 1999\u20132004. Acta Trop 100: 11-16.","DOI":"10.1016\/j.actatropica.2006.09.003"},{"key":"10.1124\/jpet.108.149872_bib21","doi-asserted-by":"crossref","unstructured":"Milord F, Loko L, Ethier L, Mpia B, and P\u00e9pin J (1993) Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness. Trans R Soc Trop Med Hyg 87: 473-477.","DOI":"10.1016\/0035-9203(93)90044-Q"},{"key":"10.1124\/jpet.108.149872_bib22","doi-asserted-by":"crossref","unstructured":"Murakami H, Ohkura A, Takanaga H, Matsuo H, Koyabu N, Naito M, Tsuruo T, Ohtani H, and Sawada Y (2005) Functional characterization of adenosine transport across the BBB in mice. Int J Pharm 290: 37-44.","DOI":"10.1016\/j.ijpharm.2004.11.005"},{"key":"10.1124\/jpet.108.149872_bib23","doi-asserted-by":"crossref","unstructured":"Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, Engelhardt B, Grammas P, Nedergaard M, Nutt J, et al. (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7: 84-96.","DOI":"10.1016\/S1474-4422(07)70326-5"},{"key":"10.1124\/jpet.108.149872_bib24","doi-asserted-by":"crossref","unstructured":"P\u00e9pin J and Khonde N (1996) Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin. Trans R Soc Trop Med Hyg 90: 183-186.","DOI":"10.1016\/S0035-9203(96)90132-7"},{"key":"10.1124\/jpet.108.149872_bib25","doi-asserted-by":"crossref","unstructured":"Priotto G, Kasparian S, Ngouama D, Ghorashian S, Arnold U, Ghabri S, and Karunakara U (2007) Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Clin Infect Dis 45: 1435-1442.","DOI":"10.1086\/522982"},{"key":"10.1124\/jpet.108.149872_bib26","doi-asserted-by":"crossref","unstructured":"Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, and Piwnica-Worms D (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci U S A 96: 3900-3905.","DOI":"10.1073\/pnas.96.7.3900"},{"key":"10.1124\/jpet.108.149872_bib27","doi-asserted-by":"crossref","unstructured":"Raseroka BH and Ormerod WE (1986) The trypanocidal effect of drugs in different parts of the brain. Trans R Soc Trop Med Hyg 80: 634-641.","DOI":"10.1016\/0035-9203(86)90162-8"},{"key":"10.1124\/jpet.108.149872_bib28","doi-asserted-by":"crossref","unstructured":"Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, Couraud PO, and Roux F (1998) Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 71: 705-715.","DOI":"10.1046\/j.1471-4159.1998.71020705.x"},{"key":"10.1124\/jpet.108.149872_bib29","doi-asserted-by":"crossref","unstructured":"Sanderson L, Dogruel M, Rodgers J, Bradley B, and Thomas SA (2008) The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain. J Neurochem 107: 1136-1146.","DOI":"10.1111\/j.1471-4159.2008.05706.x"},{"key":"10.1124\/jpet.108.149872_bib30","doi-asserted-by":"crossref","unstructured":"Sanderson L, Khan A, and Thomas S (2007) Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice. Antimicrob Agents Chemother 51: 3136-3146.","DOI":"10.1128\/AAC.00372-07"},{"key":"10.1124\/jpet.108.149872_bib31","doi-asserted-by":"crossref","unstructured":"Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, and Fridland A (1999) MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 5: 1048-1051.","DOI":"10.1038\/12487"},{"key":"10.1124\/jpet.108.149872_bib32","doi-asserted-by":"crossref","unstructured":"Schultzberg M, Ambatsis M, Samuelsson EB, Kristensson K, and van Meirvenne N (1988) Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia. J Neurosci Res 21: 56-61.","DOI":"10.1002\/jnr.490210109"},{"key":"10.1124\/jpet.108.149872_bib33","doi-asserted-by":"crossref","unstructured":"Soontornmalai A, Vlaming ML, and Fritschy JM (2006) Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138: 159-169.","DOI":"10.1016\/j.neuroscience.2005.11.011"},{"key":"10.1124\/jpet.108.149872_bib34","doi-asserted-by":"crossref","unstructured":"Sturk LM, Brock JL, Bagnell CR, Hall JE, and Tidwell RR (2004) Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue. Acta Trop 91: 131-143.","DOI":"10.1016\/j.actatropica.2004.03.010"},{"key":"10.1124\/jpet.108.149872_bib35","doi-asserted-by":"crossref","unstructured":"Varatharajan L and Thomas SA (2009) The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res doi:10.1016\/j.antiviral.2008.12.013.","DOI":"10.1016\/j.antiviral.2008.12.013"},{"key":"10.1124\/jpet.108.149872_bib36","doi-asserted-by":"crossref","unstructured":"Waalkes TP, Denham C, and DeVita VT (1970) Pentamidine: clinical pharmacologic correlations in man and mice. Clin Pharmacol Ther 11: 505-512.","DOI":"10.1002\/cpt1970114505"},{"key":"10.1124\/jpet.108.149872_bib37","unstructured":"Waalkes TP and DeVita VT (1970) The determination of pentamidine (4,4\u2032-diamidinophenoxypentane) in plasma, urine, and tissues. J Lab Clin Med 75: 871-878."},{"key":"10.1124\/jpet.108.149872_bib38","doi-asserted-by":"crossref","unstructured":"Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, et al. (2000) Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A 97: 7476-7481.","DOI":"10.1073\/pnas.120159197"},{"key":"10.1124\/jpet.108.149872_bib39","doi-asserted-by":"crossref","unstructured":"Williams SA, Abbruscato TJ, Hruby VJ, and Davis TP (1996) Passage of a delta-opioid receptor selective enkephalin, [d-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers. J Neurochem 66: 1289-1299.","DOI":"10.1046\/j.1471-4159.1996.66031289.x"},{"key":"10.1124\/jpet.108.149872_bib40","doi-asserted-by":"crossref","unstructured":"Zhang Y, Han H, Elmquist WF, and Miller DW (2000) Expression of various multi-drug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 876: 148-153.","DOI":"10.1016\/S0006-8993(00)02628-7"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652438468X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652438468X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.149872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T01:31:23Z","timestamp":1740015083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652438468X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S002235652438468X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.149872","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentamidine Movement across the Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers: Effect of Trypanosome Infection, Combination Therapy, P-Glycoprotein, and Multidrug Resistance-Associated Protein","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.149872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}